4.8 Article

Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

TIM-3 restrains anti-tumour immunity by regulating inflammasome activation

Karen O. Dixon et al.

Summary: Research demonstrates the crucial role of TIM-3 in regulating dendritic cell (DC) function, with TIM-3 deletion promoting strong anti-tumour immunity by preventing DCs from expressing a regulatory program and facilitating the maintenance of CD8(+) effector and stem-like T cells. The absence of TIM-3 in DCs leads to increased accumulation of reactive oxygen species, resulting in NLRP3 inflammasome activation, and inhibition of inflammasome activation or downstream effector cytokines IL-1 beta and IL-18 abrogates the protective anti-tumour immunity observed with TIM-3 deletion in DCs.

NATURE (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Immunology

TIM3 comes of age as an inhibitory receptor

Yochai Wolf et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Immunology

Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity

Aleksey Molodtsov et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Oncology

PD-L1 Expression in Lung Cancer

Hui Yu et al.

JOURNAL OF THORACIC ONCOLOGY (2016)